Details for New Drug Application (NDA): 205046
✉ Email this page to a colleague
The generic ingredient in DEXMEDETOMIDINE HYDROCHLORIDE is dexmedetomidine hydrochloride. There are fourteen drug master file entries for this compound. Twenty-nine suppliers are listed for this compound. Additional details are available on the dexmedetomidine hydrochloride profile page.
Summary for 205046
Tradename: | DEXMEDETOMIDINE HYDROCHLORIDE |
Applicant: | Hikma |
Ingredient: | dexmedetomidine hydrochloride |
Patents: | 0 |
Pharmacology for NDA: 205046
Mechanism of Action | Adrenergic alpha2-Agonists |
Physiological Effect | General Anesthesia |
Medical Subject Heading (MeSH) Categories for 205046
Suppliers and Packaging for NDA: 205046
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
DEXMEDETOMIDINE HYDROCHLORIDE | dexmedetomidine hydrochloride | INJECTABLE;INJECTION | 205046 | ANDA | Hikma Pharmaceuticals USA Inc. | 0143-9532 | 0143-9532-25 | 25 VIAL in 1 CARTON (0143-9532-25) / 2 mL in 1 VIAL (0143-9532-01) |
DEXMEDETOMIDINE HYDROCHLORIDE | dexmedetomidine hydrochloride | INJECTABLE;INJECTION | 205046 | ANDA | Medical Purchasing Solutions, LLC | 71872-7218 | 71872-7218-1 | 1 VIAL in 1 BAG (71872-7218-1) / 2 mL in 1 VIAL |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | INJECTABLE;INJECTION | Strength | EQ 200MCG BASE/2ML (EQ 100MCG BASE/ML) | ||||
Approval Date: | Apr 26, 2017 | TE: | AP | RLD: | No |
Complete Access Available with Subscription